室管膜下巨细胞星形细胞瘤的显微手术切除:单中心回顾性分析及荟萃分析
本研究回顾性分析31例儿童SEGA手术切除,并系统综述及荟萃分析。结果示全切除率64.5%,暂时性并发症19.3%,VPS置入6.4%,无永久并发症或死亡;术前脑积水是并发症和分流依赖的主要预测因素,双侧肿瘤为复发独立预测因素。
要点
- 显微手术切除SEGA安全有效,尤其适用于无脑积水患者。
- 术前脑积水是术后并发症和分流依赖的主要预测因素。
- 全切除亚组5年无进展生存率90.9%,单侧肿瘤达100%。
核心结论
- SEGA显微手术切除安全有效,特别适用于无脑积水患者;早期手术可能减少VPS需求和长期并发症,可作为mTOR抑制剂治疗的替代或补充。
主要发现
- 全切除率64.5%,暂时性术后并发症19.3%,VPS置入率6.4%,无永久并发症或死亡。
- 有利结局与较小肿瘤体积和无术前脑积水相关。
- 荟萃分析证实术前脑积水是术后并发症(OR 2.30)和分流依赖(OR 3.45)的主要预测因素。
- 全切除亚组5年无进展生存率90.9%,单侧肿瘤患者100%。
临床怎么用
- 对无脑积水的SEGA患者可考虑显微手术切除以控制肿瘤并避免分流依赖。
- 术前存在脑积水者应充分评估术后并发症及VPS需求风险。
- 双侧肿瘤患者术后需密切随访监测复发。
局限性
- 单中心回顾性设计,样本量有限。
- 原文未报告其他局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Subependymal giant cell astrocytomas (SEGA) are low-grade intraventricular tumors generally associated with tuberous sclerosis complex. Although mechanistic target of rapamycin inhibitors are recommended as first-line therapy for progressive SEGA without hydrocephalus, surgery is still relevant because 40% of patients are drug resistant. This study aimed to evaluate surgical outcomes in terms of tumor control, complication rates, and ventriculoperitoneal shunt (VPS) requirement, through a single-center retrospective series and a meta-analysis. METHODS: We retrospectively analyzed 31 pediatric SEGA resections performed over 2 decades at a tertiary care center. Clinical, radiological, and surgical variables were examined to identify predictors of outcome. In addition, a systematic literature review and meta-analysis were conducted to contextualize our findings. RESULTS: Gross total resection was achieved in 64.5% of cases, with a 19.3% rate of transient postoperative complications and a 6.4% incidence of VPS placement. No permanent morbidity or mortality occurred. Favorable outcome was associated with a smaller tumor volume and absence of preoperative hydrocephalus. The meta-analysis confirmed that preoperative hydrocephalus was the main predictor of postoperative complications (odds ratio 2.30) and shunt dependence (odds ratio 3.45). Five-year progression-free survival was 90.9% in the gross total resection subgroup and 100% in patients with unilateral tumors. Bilateral tumor location was an independent predictor of recurrence (hazard ratio = 17.79, P = .02). CONCLUSION: Microsurgical resection of SEGA is a safe and effective therapeutic option, particularly in patients without hydrocephalus. Early surgical intervention may reduce the need for VPS and long-term complications, offering a valid alternative or complement to mechanistic target of rapamycin inhibitor therapy, with durable tumor control especially in unilateral cases.
引用
- Sartori L, Guida L, Puget S, et al. Microsurgical Resection of Subependymal Giant Cell Astrocytoma: Single-Center Retrospective Analysis and Meta-Analysis. Neurosurgery. 2026. PMID: 41972772. doi:10.1227/neu.0000000000004044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。